Skip to main content

Table 2 Breast Cancer Related Cumulative Charges by BRCA Status and Charge Type

From: Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer

Health care charges ($US) Overall n=816 BRCAm n=134 BRCAwt n=682 BRCAm vs. BRCAwt
Mean
(SD)
Median (IQR) Mean
(SD)
Median (IQR) Mean
(SD)
Median (IQR) p-value
Facilities/ Technical 29,090
(26,802)33.8%a
24,027
(34,043)
35,130
(28,878) 40.5%
33,037
(42,145)
27,903
(26,234)
32.5%
22,458
(32,529)
0.01
Physician/ Professional 15,615
(13,126), 18.2%
12,441
(17,669)
16,207
(12,198), 18.7%
15,624
(18,967)
15,498
(13,306)
18.1%
11,908
(16,906)
0.25
Pharmacy 41,277
(69,308)
48.0%
9,313
(58,716)
35,352
(51,919) 40.8%
11,379
(54,399)
42,442
(72,209)
49.4%
8,930
(59,659)
0.65
Total Anticancer
Treatment
24,616
(56,779)
2,018
(15,804)
16,821
(38,088)
2,756
(14,673)
26,148
(59,671)
1,824
(15,995)
0.72
 Other Medication(s) 16,661
(24,471)
2,911
(27,834)
18,531
(24,484)
6,035
(30,729)
16,294
(24,470)
2,609
(26,434)
0.19
 Clinical Trial 56
(347)
0
(0)
89
(621)
0
(0)
49
(262)
0
(0)
0.93
 Chemotherapy 7,171
(14,088)
1,372
(6,575)
8,439
(14,791)
2,344
(9,463)
6,922
(13,944)
1,180
(6,124)
0.13
 Hormonal Therapy 890
(5,521)
0
(0)
769
(4,334)
0
(0)
914
(5,728)
0
(0)
0.53
 Biologic Medicine 16,499
(50,091)
0
(0)
7,524
(30,898)
0
(0)
18,262
(52,891)
0
(0)
0.02
 Chemotherapy Administration 0
(5)
0
(0)
1
(7)
0
(0)
0
(5)
0
(0)
NA
Total Charges 85,982
(94,087)
55,230
(94,787)
86,689
(75,937)
65,414
(95,894)
85,843
(97,304)
54,635
(94,085)
0.19
  1. aPercent contribution of the charge type to total charges
  2. SD Standard deviation, IQR Interquartile range